Trump set to sign executive order targeting childhood vaccines

President Donald Trump has officially signed an executive order designed to fundamentally change how the federal government approaches childhood immunizations. The directive calls for infants to receive fewer vaccines over a longer duration, a shift Trump claims will be easier for the body to handle.

Under the new plan, the nation’s vaccine schedule will be split into three distinct categories. Notably, the order advises that the combined measles, mumps, and rubella (MMR) vaccine be broken down into three separate injections, a proposal that contradicts years of established medical consensus.

Breaking Down the Jabs

During the signing in the Oval Office, Trump suggested that children are currently being injected with 'massive amounts' of fluid. "Nothing bad can happen from what we’re doing," the President stated, despite health professionals warning that these changes could leave children vulnerable to preventable diseases.

Accompanied by Health and Human Services Secretary Robert F. Kennedy Jr., Trump argued that shots should be spaced out over five different doctor visits. He cited his own personal experience as a parent, saying he followed a similar approach with his own children without issue.

The administration is also narrowing the list of universally recommended vaccines. While shots for polio and tetanus remain on the general list, others like hepatitis A and B, as well as the flu and Covid-19 shots, will now be reserved for 'high-risk' groups or decided through discussions with doctors.

Medical and Political Pushback

GOP Senator Bill Cassidy, who is also a physician, quickly condemned the move on social media. He argued that the President lacks the medical expertise to rewrite health policy, emphasizing that vaccines are safe and do not cause autism.

Cassidy further noted that splitting up vaccines actually results in children needing more injections to achieve the same level of immunity. This, he warned, could lead to increased vaccine hesitancy and decreased safety for American children.

Logistical questions also remain, as the individual components of the MMR vaccine are not currently sold separately in the United States. HHS has been tasked with working with private companies to make these separate shots available within the next 90 days.